Global and Targeted Pathway Impact of Gliomas on White Matter Integrity Based on Lobar Localization

Primary brain tumors comprise 28% of all tumors and 80% of malignant tumors. Pathophysiology of high-grade gliomas includes significant distortion of white matter architecture, necrosis, the breakdown of the blood brain barrier, and increased intracranial pressure. Diffusion tensor imaging (DTI), a diffusion weighted imaging technique, can be used to assess white matter architecture. Use of DTI as a non-invasive pathophysiological tool to analyze glioma impact on white matter microstructure has yet to be fully explored. Preliminary assessment of DTI tractography was done as a measure of intracranial tumor impact on white matter architecture. Specifically, we addressed three questions: 1) whether glioma differentially affects local white matter structure compared to metastasis, 2) whether glioma affects tract integrity of major white matter bundles, 3) whether glioma lobe localization affects tract integrity of different white matter bundles. In this study, we retrospectively investigated preoperative DTI scans from 24 patients undergoing tumor resection. Fiber tractography was estimated using a deterministic fiber tracking algorithm in DSI (diffusion spectrum imaging) Studio. The automatic anatomical labeling (AAL) atlas was used to define the left and right (L/R) hemisphere regions of interest (ROI). In addition, the John Hopkins University (JHU) White Matter Atlas was used to auto-segment major white matter bundle ROIs. For all tracts derived from ROI seed targets, we computed the following parameters: tract number, tract length, fractional anisotropy (FA), axial diffusivity (AD), mean diffusivity (MD), and radial diffusivity (RD). The DTI tractography analysis revealed that white matter integrity in the hemisphere ipsilateral to intracranial tumor was significantly compromised compared to the control contralateral hemisphere. No differences were observed between high vs low-grade gliomas, however, gliomas induced significantly greater white matter degradation than metastases. In addition, targeted analysis of major white matter bundles important for sensory/motor function (i.e., corticospinal tract and superior longitudinal fasciculus) revealed tract-parameter specific susceptibility due to the presence of the tumor. Finally, major tract bundles were differentially affected based on lobar localization of the glioma. These DTI-based tractographic analyses complement findings from gross histopathological examination of glioma impact on neural tissue. Global and focal white matter architecture, ipsilateral to glioma, shows higher rates of degradation or edema – based on DTI tractographic metrics – in comparison to normal brain or metastases. Gliomas, which arise in the parietal lobe, also have a higher negative impact (potentially due to increased edema) on white matter integrity of the superior longitudinal fasciculus(SLF) than those which arise in the frontal lobe. Future studies will focus on using preoperative and postoperative tractography to predict functional deficits following resective surgery.

[1]  Sterling C. Johnson,et al.  Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation , 2014, NeuroImage: Clinical.

[2]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[3]  F. Tomasello,et al.  Functional Reconstruction of Motor and Language Pathways Based on Navigated Transcranial Magnetic Stimulation and DTI Fiber Tracking for the Preoperative Planning of Low Grade Glioma Surgery: A New Tool for Preservation and Restoration of Eloquent Networks. , 2017, Acta neurochirurgica. Supplement.

[4]  S. Shahzadi,et al.  Diffusion Tensor Imaging for Glioma Grading: Analysis of Fiber Density Index , 2017, Basic and clinical neuroscience.

[5]  Hangyi Jiang,et al.  DtiStudio: Resource program for diffusion tensor computation and fiber bundle tracking , 2006, Comput. Methods Programs Biomed..

[6]  M. Kraut,et al.  Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo , 2002, Annals of neurology.

[7]  Paul M. Thompson,et al.  Along-tract statistics allow for enhanced tractography analysis , 2012, NeuroImage.

[8]  J. Mcculloch,et al.  Glioma Pathophysiology: Insights Emerging from Proteomics , 2010, Brain pathology.

[9]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[10]  W. Tseng,et al.  Sparse Solution of Fiber Orientation Distribution Function by Diffusion Decomposition , 2013, PloS one.

[11]  A. Alexander,et al.  Diffusion tensor imaging of the brain , 2007, Neurotherapeutics.

[12]  L. O'Donnell,et al.  White matter tractography for neurosurgical planning: A topography-based review of the current state of the art , 2017, NeuroImage: Clinical.

[13]  B. Meyer,et al.  Associations between clinical outcome and navigated transcranial magnetic stimulation characteristics in patients with motor-eloquent brain lesions: a combined navigated transcranial magnetic stimulation-diffusion tensor imaging fiber tracking approach. , 2017, Journal of neurosurgery.

[14]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[15]  Randy L. Gollub,et al.  Reproducibility of quantitative tractography methods applied to cerebral white matter , 2007, NeuroImage.

[16]  Raymond Sawaya,et al.  Necrosis and Glioblastoma: A Friend or a Foe? A Review and a Hypothesis , 2002, Neurosurgery.

[17]  J D Pickard,et al.  Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion? , 2003, Clinical radiology.

[18]  R. Bammer Basic principles of diffusion-weighted imaging. , 2003, European journal of radiology.

[19]  Thomas Ludwig,et al.  Glioblastoma cells release factors that disrupt blood-brain barrier features , 2004, Acta Neuropathologica.

[20]  R. Stupp,et al.  Standards of care and novel approaches in the management of glioblastoma multiforme , 2014, Chinese journal of cancer.